ArticleFrontiers in pharmacology2026
Wogonoside alleviates metabolic dysfunction-associated steatohepatitis by modulating AMPK and xCT/GPX4 pathways to restrain lipid dysregulation and ferroptosis.
Daoping Wang et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.